Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular-IDCW Reinvestment

Fund Details

NAV 20.8511

Sub-Type Sectoral-Pharma

Rating 2

Min. SIP Amount ₹100.0

Fund Age(Year) 5.16

Fund Size(in Crores) 175.55

Fund Performance

1 Month 0.07%

3 Month 3.57%

6 Month 9.46%

1 Year 6.68%

3 Year 19.09%

5 Year 13.63%

Know This Fund

As on 22 Dec 2025

Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.

Equity (99.89%) Market Cap Large Cap 29.57 Mid Cap 31.77 Small Cap 38.55 Top Sectors Healthcare 99.89 Top Holding Illumina Inc. (USA) 0.16 Ajanta Pharma 0.73 Max Healthcare Institute 5.92 Eli Lilly 6.83 Laurus Labs 2.37 Biocon 1.39 Syngene International 0.77 Danaher Corporation 1.15 Glenmark Pharmaceuticals 1.98 Vertex Pharmaceuticals Inc. (USA) 0.88 Merck & Co Inc (US) 2.07 Glaxosmithkline Pharma 0.71 Gilead Sciences Inc. (USA) 1.23 Piramal Pharma 0.73 Dr. Reddy's Laboratories 4.47 AbbVie Inc 3.17 Sun Pharmaceutical Industries 11.5 Iqvia Holdings 0.31 Agilent Technologies Inc 0.34 Novo Nordisk A/S - ADR 1.25 Apollo Hospitals Enterprise 5.18 Becton Dickinson And Co 0.44 Cohance Lifesciences 0.42 Ipca Laboratories 1.33 Zydus Lifesciences 1.24 Novartis AG 1.96 Intuitive Surgical Inc. (USA) 1.62 Global Health 0.66 Cipla 5.66 Lupin 3.42 Stryker Corp 1.01 Medtronic 1.07 Torrent Pharmaceuticals 2.88 Aurobindo Pharma 2.1 Amgen Inc. (USA) 1.47 Thermo Fisher Scientific Inc 1.76 Gland Pharma 0.85 Mankind Pharma 1.82 Alkem Laboratories 1.78 Regeneron Pharmaceuticals Inc 0.64 Abbott Laboratories 1.77 Divi's Laboratories 5.06 Fortis Healthcare 2.95 Johnson & Johnson 3.93 Narayana Hrudayalaya 0.91

Debt & Others (0.10999999999999999%) Sector Allocation Net Payables -0.38 Cash 0 CBLO 0.49 Debt Credit Ratings Debt Category Others 0.11

Comparison with same funds

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -1.66% Ret 1Y -1.96% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -2.13% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Charges & Taxes Expense Ratio

Returns are taxed as per your Income Tax Slab.

Expense Ratio (Inclusive of GST): 1.06%

Exit Load 0%

Stamp Duty 0.005%

Fund Management

The various expenses, charges and taxes associated with your Mutual Fund

Amit Vora

Education Mr. Vora has done B.Com from University of Mumbai

Experience Antique Stock Broking Ltd, D.E. Shaw India Securities Pvt. Ltd, Derivium Tradition Securities (India) Pvt Ltd, Tower Capital & Securities Pvt Ltd and B&K Securities

Bhavesh Jain

Education Mr. Jain is a MMS (Finance) from Mumbai University.

Experience Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.

Riskometer

Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.

Principal at very high risk

AMC and Fund details

Rank (total sets) 1

Date of Incorporation 2020-10-26

Total AUM 2025-11-30

The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.